Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

219
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
219
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

216
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
216
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

447
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
447
Data Validation01:15

Data Validation

535
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
535
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

286
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
286
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

491
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
491

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advanced glucose control strategies leveraging Raman spectroscopy for optimized mammalian cell culture manufacturing.

Biotechnology progress·2026
Same author

Firm, Yellow, and Now Fluid-Filled!

Clinical and experimental dermatology·2026
Same author

Capacitance Technology Enables Automated Feeding, Improved Expansion, and Higher Throughput of CAR-T Cell Stirred-Tank Bioreactor Cultures.

Biotechnology journal·2026
Same author

Bioprocess optimisation via joint machine learning and metabolic modelling.

Metabolic engineering·2026
Same author

Multimodal Chromatography in the Downstream Processing of mAb-Based Products: Mechanisms, Strategies, and Applications.

Biotechnology and bioengineering·2026
Same author

Turning struggles into strengths: A qualitative exploration of academic difficulty in medical school.

Medical teacher·2026

Related Experiment Video

Updated: Jan 5, 2026

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
08:15

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells

Published on: September 28, 2018

11.4K

Multivariate Data Analysis Methodology to Solve Data Challenges Related to Scale-Up Model Validation and Missing Data

Stephen Goldrick1,2, Viktor Sandner3, Matthew Cheeks2

  • 1The Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, University College London, Gower Street, London, WC1E 6BT, UK.

Biotechnology Journal
|October 17, 2019
PubMed
Summary

Multivariate data analysis (MVDA) offers powerful insights into biomanufacturing data. This study introduces a standardized MVDA methodology to improve data analysis and address challenges in therapeutic drug production.

Keywords:
cell culturemissing datamultivariate data analysisscale-up/downtwo one-sided test

More Related Videos

Comparison of Scale in a Photosynthetic Reactor System for Algal Remediation of Wastewater
05:40

Comparison of Scale in a Photosynthetic Reactor System for Algal Remediation of Wastewater

Published on: March 6, 2017

9.5K
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.6K

Related Experiment Videos

Last Updated: Jan 5, 2026

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
08:15

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells

Published on: September 28, 2018

11.4K
Comparison of Scale in a Photosynthetic Reactor System for Algal Remediation of Wastewater
05:40

Comparison of Scale in a Photosynthetic Reactor System for Algal Remediation of Wastewater

Published on: March 6, 2017

9.5K
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.6K

Area of Science:

  • Biopharmaceutical Manufacturing
  • Data Science
  • Process Analytical Technology

Background:

  • Multivariate data analysis (MVDA) is underutilized in biomanufacturing.
  • Complex, high-dimensional data from therapeutic drug manufacture requires advanced analysis.
  • Standardization is needed to promote MVDA adoption in the biopharmaceutical industry.

Purpose of the Study:

  • To outline a novel, standardized methodology for multivariate data analysis (MVDA) in biomanufacturing.
  • To demonstrate the application of this methodology in solving both small and big data challenges.
  • To promote the effective use of MVDA for enhanced understanding and data leverage.

Main Methods:

  • Development of a novel MVDA methodology.
  • Application of the methodology to a "small data" case study comparing large-scale and scale-down model data.
  • Application of the methodology to a "big data" case study involving prediction of missing data in a cloning study.

Main Results:

  • A new quantitative metric for equivalence was established using a two one-sided test and principal component analysis (PCA) in the "small data" example.
  • Accurate predictions of critical missing data were achieved in the "big data" example using partial least squares (PLS) modeling.
  • The methodology demonstrated the importance of data pre-processing, restructuring, and visualization.

Conclusions:

  • The proposed MVDA methodology provides a standardized approach for biopharmaceutical data analysis.
  • MVDA, when applied effectively, can solve complex challenges in biomanufacturing, from scale-down model equivalence to missing data imputation.
  • Emphasis on data pre-processing, restructuring, and visualization is crucial for successful MVDA implementation.